| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/11/2006 | WO2005092924A3 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 05/11/2006 | WO2005077116A3 Recombinant dna for gene suppression |
| 05/11/2006 | WO2005054439A3 Small interfering rna (sirna)-mediated heritable gene manipulation in plants |
| 05/11/2006 | WO2005048951A3 A novel human g-protein coupled receptor, hgprbmy8, expressed highly in brain |
| 05/11/2006 | WO2005047461A3 Polypeptide display libraries and methods of making and using thereof |
| 05/11/2006 | WO2005024042A3 Aptamers and methods for their in vitro selection and uses thereof |
| 05/11/2006 | WO2005019414A3 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 05/11/2006 | WO2005016504A3 Disruption of acc synthase genes to delay senescence in plants |
| 05/11/2006 | WO2004108353A3 Integrated tool with interchangeable wet processing components and automated calibration systems |
| 05/11/2006 | WO2004033646A3 Process for the biological production of 1,3-propanediol with high yield |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060101545 Plant stably transformed with recombinant expression construct comprising a soybean promoter and a heterologous nucleic acid fragment operably linked; genetic engineering |
| 05/11/2006 | US20060101544 Phospholipid:diacylglycerol acyltransferases |
| 05/11/2006 | US20060101543 Production of hydroxylated fatty acids in genetically modified plants |
| 05/11/2006 | US20060101542 Insect resistance |
| 05/11/2006 | US20060101541 RCc3 regulatory elements for use in plants |
| 05/11/2006 | US20060101540 Methods of transforming corn |
| 05/11/2006 | US20060101539 Cryopreservation of cells |
| 05/11/2006 | US20060101538 Expressing DNA conferring transgene-dependent incompatibility; prevents mating with wild-type/native species and spreading recombinant genes into environment |
| 05/11/2006 | US20060101537 Eucalyptus urophylla transformation and selection |
| 05/11/2006 | US20060101536 Eucalyptus urophylla transformation and regeneration |
| 05/11/2006 | US20060101535 DNA construct comprising a promoter linked to gene involved in monolignol biosynthetic pathway |
| 05/11/2006 | US20060101534 Transgenic mice containing beta3GalT2 gene disruptions |
| 05/11/2006 | US20060101533 Transgenic mice containing TMEM3 beta-1,3-N-acetylglucosaminyltransferase gene disruptions |
| 05/11/2006 | US20060101532 Methods for the identification of compounds for the treatment of Alzheimer's disease |
| 05/11/2006 | US20060101530 Rors as modifiers of the p21 pathway and methods of use |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060101528 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment |
| 05/11/2006 | US20060100611 Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage |
| 05/11/2006 | US20060100422 Pichia pastoris formate dehydrogenase and uses therefor |
| 05/11/2006 | US20060100420 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 05/11/2006 | US20060100418 Cultured xenopus cell line expressing mutated apc |
| 05/11/2006 | US20060100416 Novel substitution mutant receptors and their use in an nuclear receptor-based inducible gene expression system |
| 05/11/2006 | US20060100152 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules |
| 05/11/2006 | US20060100149 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 05/11/2006 | US20060100145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060099710 Vector for improved in vivo production of proteins |
| 05/11/2006 | US20060099709 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 05/11/2006 | US20060099708 Methods for diagnosis and treatment of MDK1 signal transduction disorders |
| 05/11/2006 | US20060099700 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control |
| 05/11/2006 | US20060099699 Comprises nucleotide sequences coding galactosyltransferase for use in treatment or prevention of aberrant cell surface glycosylation associated with tumor progression |
| 05/11/2006 | US20060099698 Glucose dehydrogenases |
| 05/11/2006 | US20060099695 Method of separating poly-3-hydroxyalkanoic acid |
| 05/11/2006 | US20060099692 Microorganisms and processes for enhanced production of pantothenate |
| 05/11/2006 | US20060099691 Production of complex carbohydrates |
| 05/11/2006 | US20060099689 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 05/11/2006 | US20060099687 14926 Receptor, a novel G-protein coupled receptor |
| 05/11/2006 | US20060099686 Generation of artificial binding proteins on the basis of ubiquitin proteins |
| 05/11/2006 | US20060099685 Recombinant expression of factor VIII in human cells |
| 05/11/2006 | US20060099684 Polypeptide of given sequence; inhibiting endothelial cell proliferation; restenosis, cancer, eye disorders |
| 05/11/2006 | US20060099683 Isolated hOAT polypeptide |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099680 Yeast transformant into which genes associated with synthesis system of O-fucosylated protein are introduced |
| 05/11/2006 | US20060099679 nucleic acids, vectors, and host cells; monomeric fluorescent proteins with increased photostability and the longest-wavelength emissions (e.g., 649 nm) yet observed for a red fluorescent protein |
| 05/11/2006 | US20060099678 Method of inducing homologous recombination of somatic cell |
| 05/11/2006 | US20060099677 DNA/RNA transduction technology and its clinical and basic applications |
| 05/11/2006 | US20060099675 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 05/11/2006 | US20060099674 Chromatographic purification of recombinant human erythropoietin |
| 05/11/2006 | US20060099673 Novel recombinant gene expression method by stop codon suppression |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099670 Method for the genetic modification of organisms of the genus blakeslea, corresponding organisms and the use of the same |
| 05/11/2006 | US20060099659 Method to detect IgE |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099655 Cloning of a human cytoplasmic polyadenylation element binding protein (hCPEB) with sequence-specific RNA binding activity; examining reproductive potential of a oocyte; gene expression |
| 05/11/2006 | US20060099645 Methods and reagents for assaying molecular interactions |
| 05/11/2006 | US20060099641 Method of making libraries and anti-ligands |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099637 Oligonucleotide and method for detecting Verotoxin |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099633 Human FcgammaRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof |
| 05/11/2006 | US20060099629 Detecting uropathogenic E. coli genes by testing the strain for the ability to grow in the presence of D-serine; identification of new E. Coli-specified pathogenicity factors may facilitate the development of new methods of treating or preventing urinary tract infections |
| 05/11/2006 | US20060099619 Detection and quantification of miRNA on microarrays |
| 05/11/2006 | US20060099616 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing to skip hybridization |
| 05/11/2006 | US20060099615 Method of detecting target nucleotide sequence, structure and preparation of the detection target used for working the detection method, and assay kit for detecting the target nucleotide sequence |
| 05/11/2006 | US20060099613 Use of antisense oligonucleotide libraries for identifying gene function |
| 05/11/2006 | US20060099611 In vivo affinity maturation scheme |
| 05/11/2006 | US20060099602 Nucleic acid library and protein library |
| 05/11/2006 | US20060099601 Novel compositions and processes for analyte detection, quantification and amplification |
| 05/11/2006 | US20060099597 Method of isolating nucleic acid having desired functional property and kit therefor |
| 05/11/2006 | US20060099594 Method of predicting genetic risk for hypertension |
| 05/11/2006 | US20060099593 Method of diagnosing integration dysfunction syndrome using blood |
| 05/11/2006 | US20060099592 Method for the synthesis of a bifunctional complex |
| 05/11/2006 | US20060099591 Diagnosis of chronic rejection |
| 05/11/2006 | US20060099590 Method of diagnosing risk of restenosis after coronary angioplasty |
| 05/11/2006 | US20060099589 Gene shuffling by template switching |
| 05/11/2006 | US20060099588 producing an isolated polynucleotide sequence encoding chymosin which is modified so as to comprise at least one N X-T-glycosylation site and a method for producing such a polypeptide; milk clotting; cheesemaking |
| 05/11/2006 | US20060099578 Mitochondrial biology expression arrays |
| 05/11/2006 | US20060099577 Method for preparative production of long nucleic acids by pcr |
| 05/11/2006 | US20060099571 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment |
| 05/11/2006 | US20060099224 Methods and compositions concerning poxviruses and cancer |
| 05/11/2006 | US20060099221 Method of screening anti-mycobacterial molecules |
| 05/11/2006 | US20060099219 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process |
| 05/11/2006 | US20060099218 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 05/11/2006 | US20060099216 Peptide delivery |
| 05/11/2006 | US20060099215 Walnut and ryegrass allergens |
| 05/11/2006 | US20060099209 prostate and breast carcinoma; used for diagnosis to identify individuals with the high probability of having a malignant disease |
| 05/11/2006 | US20060099197 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/11/2006 | US20060099190 Method for transdifferentiating mesenchymal stem cells into neuronal cells |
| 05/11/2006 | US20060099188 Tumor-specific promoter |